Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of helicobacter pylori in patients with chronic gastritis with or without peptic ulceration

American Journal of Gastroenterology

Volumn 93, Issue 10, 1998, Pages 1909-1913

  Stack, W A ^a,b   Knifton, A ^a   Thirlwell, D ^a   Cockayne, A ^a   Jenkins, D ^a   Hawkey, C J ^a   Atherton, J C ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CARBON 13; CLARITHROMYCIN; METRONIDAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RABEPRAZOLE; UREA; UREASE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BREATH ANALYSIS; CHRONIC GASTRITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRAM NEGATIVE INFECTION; HEADACHE; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH BIOPSY; TASTE DISORDER; TREATMENT OUTCOME; TREATMENT PLANNING;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AMOXICILLIN; ANTI-ULCER AGENTS; BENZIMIDAZOLES; CLARITHROMYCIN; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; PEPTIC ULCER; PROTON-TRANSLOCATING ATPASES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0344609243     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00582.x     Document Type: Article

References (19)

1. 1. Robinson M, Maton PN, Rodriguez S, et al. Effects of oral rabeprazole on oesophageal and gastric pH in patients with gastro-oesophageal disease. Aliment Pharmacol Ther 1997;11:973-80.
2. 2. Cloud MI, Olovich K, Enas N, et al. LY307640 versus placebo in healing duodenal ulcers. Gastroenterology 1995;108:A73 (abstract).
3. 3. Dekkers CPM, Beker JA, Thjodleifsson B, et al. Rabeprazole sodium 20 mg once daily is similar to omeprazole once daily in the healing of gastric ulcer. Gastroenterology 1997;112:A99 (abstract).
4. 4. Humphries TJ, Spera A, Breiter J, et al. Rabeprazole sodium once daily is superior to ranitidine 150 mg QID in the healing of erosive or ulcerative gastroesophageal disease. Gastroenterology 1996;110:A139 (abstract).
5. 5. Humphries TJ, Spera A, Breiter J, et al. Rabeprazole sodium once daily is superior to ranitidine 150 mg BID in the healing of active duodenal ulcer. Gastroenterology 1997;112:A154 (abstract).
6. 6. Beker JA, Dekkers CPM, Thjodleifsson B, et al. Rabeprazole sodium 20 mg once daily is similar to omeprazole 20 mg once daily in the healing of active duodenal ulcer. Gastroenterology 1997;112:A70 (abstract).
7. 7. Williams M, Sercome J, Pounder RE. Comparison of the effects of rabeprazole and omeprazole on 24-hour intragastric acidity and plasmin gastrin concentration in healthy subjects. Gut 1997;41(suppl 3): A96 (abstract).
8. 8. NIH, Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
9. 9. Goddard A, Logan R. One-week low dose triple therapy; new standards for Helicobacter pylori treatment. Eur J Gastroenterol Hepatol 1995;7:1-3.
10. 10. The Maastricht Consensus Report. Current European concepts in the management of H. pylori infection. Gut 1997;41:8-13.
11. 11. Penston JG, McColl KE. Eradication of Helicobacter pylori: An objective assessment of current therapies. Br J Clin Pharmacol 1997;43: 223-43.
12. 12. Goddard AF, Spiller RC. Helicobacter pylori eradication in clinical practice: One-week low dose triple therapy is preferable to classical bismuth based triple therapy. Aliment Pharmacol Ther 1996;10:1009-13.
13. 13. van der Hulst RWM, Keller JJ, Rauws EAJ, et al. Treatment of Helicobacter pylori infection: A review of the world literature. Helicobacter 1996;1:6-19.
14. 14. Humphries TJ, Bassion S, Spanyers SA. Pilot studies on the effects of rabeprazole sodium (E3810), amoxicillin and placebo on the eradication of H. pylori. Am J Gastroenterol 1996;91:A1914 (abstract).
15. 15. Logan RPH, Polson RJ, Misiewicz JJ, et al. A simplified single sample 13C-Urea Breath Test for detection of Helicobacter pylori; comparison with histology, culture and ELISA serology. Gut 1991;32:1461-4.
16. 16. Fujisaki H, Shibata H, Oketani K, et al. Inhibition of acid secretion by E3810 and omeprazole, and their reversal by gluthathione. Biochem Pharmacol 191;42:321-8.
17. 17. Working Party of the European H. pylori Study Group. Guidelines for clinical trials in H. pylori infection. Gut 1997;42:S10-S18.
18. 18. Lind T, Velduyzen van Zanten S, Unge P, et al. Eradication of H. pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH-1 study. Helicobacter 1996;3:138-44.
19. 19. Lind T, Megraud F, Bardhan KD, et al. The MACH-2 study: Antimicrobial resistance in H. pylori therapy - The impact of omeprazole. Gut 1997;41:SI A89 (abstract).